Evista: A Treatment for Postmenopausal Osteoporosis
Evista, generically known as raloxifene, is a medication used to prevent and treat osteoporosis in postmenopausal women. It mimics estrogen’s effects on bones, aiding in maintaining bone density and reducing fractures. Additionally, Evista lowers the risk of invasive breast cancer, especially in women with osteoporosis or high cancer risk. As a selective estrogen receptor modulator (SERM), it offers estrogen benefits in some tissues while blocking effects in others, like the breast. Common side effects include hot flashes, leg cramps, and an increased risk of blood clots, making thorough health discussions crucial.
